Helena Laboratories Corporation

Helena Laboratories Corporation, headquartered in Beaumont, Texas, manufactures electrophoresis analyzers, reagents, immunofixation testing products, and related clinical laboratory diagnostic equipment, competing as a prime contractor (100% of awards) on full-and-open federal procurements with no set-aside designations across most of its portfolio—though a recent $3.775 million Blanket Purchase Agreement with Veterans Integrated Service Network 20 carries a total small business set-aside. The company is a for-profit manufacturer with a subsidiary, Labcon, North America, and operates across 26 federal customer agencies with a federal award footprint of 772 prime contracts and IDVs totaling $16.7 million in combined potential value, of which $6.5 million has been obligated.

Helena Laboratories' customer base concentrates heavily within the Department of Veterans Affairs system. The top five customers by potential value account for 80% of combined potential value: Veterans Integrated Service Network 21 anchors the portfolio with 11 awards and $4.4 million in potential value, followed by Veterans Integrated Service Network 20 (4 awards, $4.3 million), Veterans Integrated Service Network 4 (17 awards, $1.6 million), Veterans Integrated Service Network 10 (22 awards, $1.6 million), and Veterans Integrated Service Network 17 (13 awards, $1.4 million). VISN 10 places the highest volume of individual orders (22 awards) despite lower aggregate dollar value, whereas VISN 21 and VISN 20 anchor most of the dollars through larger indefinite delivery vehicles. The Department of the Army and Department of the Navy Bureau of Medicine and Surgery each hold 17 to 18 awards but at lower individual values.

Helena Laboratories operates across multiple IDIQs and blanket purchase agreements spanning the VA network. The top parent vehicles include Indefinite Delivery Contract V673P5492 (56 task orders, $207 thousand combined potential value), Indefinite Delivery Contract V603P3419 (16 task orders, $216 thousand combined potential value), Blanket Purchase Agreement VA261BP0046 (6 task orders, $78 thousand combined potential value), Federal Supply Schedule GS00S27022 (5 task orders), and Indefinite Delivery Contract 36C25723D0009 (4 task orders, $166 thousand combined potential value). Recent named IDVs include a $3.775 million single-award BPA with VISN 20 for electrophoresis kits, equipment, and maintenance through January 31, 2031 (total small business set-aside); a $725 thousand single-award IDC with VISN 17 for CTX electrophoresis analyzers and reagents through November 30, 2028; a $500 thousand single-award IDC with VISN 10 for electrophoresis testing services through July 31, 2030; a $241,362 single-award BPA with VISN 19 for electrophoresis urine and serum kits through July 31, 2029; and a $220 thousand single-award IDC with VISN 17 for electrophoresis immunofixation products through November 30, 2027. Individual task orders under these vehicles do not exceed $250 thousand. Representative prime awards include a $329,653.88 total small business purchase order from VISN 4 in February 2023 for electrophoresis lab supplies and reagents supporting the Pittsburgh VA Medical Center through February 2028; a $133,328.40 total small business purchase order from VISN 21 in February 2022 for electrophoresis equipment and capabilities through September 2025; a $91,644.84 purchase order from VISN 4 in December 2023 for automated electrophoresis equipment and supplies; and a $81,473 purchase order from Veterans Integrated Service Network 10 in September 2026 for a SPIFE TOUCH electrophoresis analyzer at Cleveland VAMC.

Helena Laboratories' award category concentration reflects its manufacturing core. The top NAICS codes across the portfolio are In-Vitro Diagnostic Substance Manufacturing (102 awards), Analytical Laboratory Instrument Manufacturing (59 awards), and Drugs and Druggists' Sundries Merchant Wholesalers (17 awards). The top PSCs are Laboratory Equipment and Supplies (358 awards), In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (215 awards), and Medical and Surgical Instruments, Equipment, and Supplies (72 awards). Activity has remained relatively flat over the past five years—7 awards in 2022, rising to 10 in 2025, with 7 awards in 2026 year-to-date—with 8 awards (combined potential value $788 thousand) completing within the next twenty-four months and facing recompete. Helena Laboratories holds no federal subcontract work in the source data.